Results 131 to 140 of about 362 (158)
Some of the next articles are maybe not open access.
Status of the ‘consensus nomenclature rules in radiopharmaceutical sciences’ initiative
Nuclear Medicine and Biology, 2019Antony Gee +2 more
exaly +4 more sources
23rd International Symposium on Radiopharmaceutical Sciences
Journal of Labelled Compounds and Radiopharmaceuticals, 2019exaly +2 more sources
2023
The Federal Register of the USA initially described radiopharmaceuticals as radioactive agents—natural substances based on carbon (14C) and potassium (40K)—or biological products that include unstable nuclei that may spontaneously decay and release photons or nuclear particles.
null Diksha +4 more
openaire +1 more source
The Federal Register of the USA initially described radiopharmaceuticals as radioactive agents—natural substances based on carbon (14C) and potassium (40K)—or biological products that include unstable nuclei that may spontaneously decay and release photons or nuclear particles.
null Diksha +4 more
openaire +1 more source
RADIOPHARMACEUTICALS INPHARMACEUTICAL SCIENCE
2022Modern diagnostic and therapeutic procedures using radiopharmaceuticals' original radiotracers are made possible by the medical specialty known as radiopharmaceuticals (Nuclear Medicine) (drugs linked to a radioactive isotope). Since radiopharmaceuticals are regarded as a unique class of medications on a global scale, each member nation has created a ...
Ravindra Mishra +4 more
openaire +1 more source
Chelating Agents and their Use in Radiopharmaceutical Sciences
Mini-Reviews in Medicinal Chemistry, 2011Radiometal nuclides can serve as diagnostic markers in molecular imaging or can be used in therapeutic settings for a rising number of human afflictions. For the targeted delivery of these medically interesting ions, appropriate chelating agents forming stable complexes are of fundamental importance.
B, Wängler +3 more
openaire +2 more sources
2022
Nowadays all the fields of sciences such as chemistry, medicines, biology, and pharmacology exploiting the use of a radionuclide as medication or other biologically active molecule. These molecules are very potent and play a very big role in improving human life by treating many diseased conditions.
openaire +1 more source
Nowadays all the fields of sciences such as chemistry, medicines, biology, and pharmacology exploiting the use of a radionuclide as medication or other biologically active molecule. These molecules are very potent and play a very big role in improving human life by treating many diseased conditions.
openaire +1 more source
Internal Dosimetry in the Use of Radiopharmaceuticals in Therapy-Science at a Crossroads?
Cancer Biotherapy and Radiopharmaceuticals, 1999Because of expanding therapeutic applications, radionuclide dosimetry is in a stage of reference "man" based system to systems for "patient-specific dosimetry." Although the challenges for the latter system are substantial, patient-specific radiation dosimetry has greater relevance to treatment planning.
openaire +2 more sources
The Lancet Oncology
Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th century, the systematic use of radionuclides in medicine only gradually increased over the subsequent hundred years.
Andrew M, Scott +17 more
openaire +2 more sources
Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th century, the systematic use of radionuclides in medicine only gradually increased over the subsequent hundred years.
Andrew M, Scott +17 more
openaire +2 more sources
Radiopharmaceutical imaging based on 3D-CZT Compton camera with 3D-printed mouse phantom
Physica Medica, 2022Zhiyang Yao, Fei Cai, Xiaobin Tang
exaly
European Journal of Nuclear Medicine and Molecular Imaging, 2021
Yong Du, Robert Hobbs, George Sgouros
exaly
Yong Du, Robert Hobbs, George Sgouros
exaly